Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa-carbidopa intrajejunal gel.

导出 LinkOut

翻译打印收藏纠错

作者： Marta,Melis ^[1] ; Sarah,Vascellari ^[2] ; Maria Laura,Santoru ^[3] ; Valentina,Oppo ^[4] ; Margherita,Fabbri ^[5] ; Marianna,Sarchioto ^[6] ; Daniela,Murgia ^[4] ; Maurizio,Zibetti ^[5] ; Leonardo,Lopiano ^[5] ; Alessandra,Serra ^[2] ; Vanessa,Palmas ^[2] ; Silvia,Pisanu ^[2] ; Daniela,Perra ^[2] ; Veronica,Madau ^[2] ; Roberto,Cusano ^[7] ; Paolo,Uva ^[7] ; Alessandra,Mereu ^[8] ; Paolo,Contu ^[8] ; Micaela,Morelli ^[9] ; Luigi,Atzori ^[3] ; Maurizio,Melis ^[4] ; Aldo,Manzin ^[2] ; Giovanni,Cossu ^[4]

作者单位： Department of Neurology, AOU Policlinico Monserrato, Cagliari, Italy. ^[1] Department of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, Cagliari, Italy. ^[2] Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy. ^[3] Department of Neurology, AO Brotzu, Cagliari, Italy. ^[4] Department of Neurosciences Rita Levi Montalcini, University of Torino, Turin, Italy. ^[5] Neurosciences Research Centre, Molecular and Clinical Sciences Research Institute, St. George's University of London, London, UK. ^[6] CRS4, Science and Technology Park Polaris, Piscina Manna, Cagliari, Italy. ^[7] Dipartimento di Scienze Mediche e Sanità Pubblica, Università degli Studi di Cagliari, Cagliari, Italy. ^[8] Section of Neuroscience, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy. ^[9]

关键词 LCIG Parkinson duodopa levodopa microbiota